Transplantation Immunology Flashcards
syngeneic graft
transplant between IDENTICAL twins
allogeneic graft
transplant between genetically distinct individuals
xenogeneic graft
transplant between different species
cross-match test
the direct assessment of ABO/Rh compatibility in blood transfusion
important factors for blood transfusions
*erythrocytes do NOT express HLA class I or II molecules
*BUT erythrocytes DO express ABO and rhesus (Rh) antigens
what are the immunoglobulin class found in blood plasma (ABO) vs. Rh
ABO has IgM antibodies
Rh has IgG antibodies
acute hemolytic transfusion reaction
*ABO group incompatibility causes host antibodies to attack transfused RBCs in a type II HSR
*presentation = fever, hypotension, tachypnea, tachycardia, hemoglobinuria, and jaundice WITHIN 1 HOUR OF TRANSFUSION
transplant rejection - basics
HOST immune cells attack transplanted organ
graft-versus-host disease - basics
TRANSPLANTED immune cells attack the host in a type IV HSR
graft-vs-host disease - details
- T cells are present in the graft
- upon transplant, they travel to the lymph nodes of the host and proliferate
- T cells attack “foreign” host cells and cause severe organ dysfunction
graft-vs-host disease - presentation
maculopapular rash
jaundice
diarrhea
hepatosplenomegaly
graft-vs-host disease - treatment
immune suppression (cyclofosamide after receiving the graft)
graft-versus-host disease - grading
graded from I to IV, based on increasing RASH and DIARRHEA OUTPUT
transplant rejection and histocompatibility antigens
recipient response against major AND minor histocompatibility antigens
minor histocompatibility antigens
intracellular proteins that vary between individuals in a population
alloantigens
term used to describe major and minor histocompatibility antigens together
2 types of allorecognition
- direct (MAJOR histocompatibility antigens)
- indirect (MINOR histocompatibility antigens)
hyperacute transplant rejection - timing
within minutes to an hour
hyperacute transplant rejection - cause
pre-existing recipient antibodies react to donor antigens (often HLA)
hyperacute transplant rejection - mechanism
antibodies deposit in vasculature of graft, leading to thrombosis and subsequent ischemia/necrosis of the graft
hyperacute transplant rejection - treatment
removal of organ
acute transplant rejection - timing
weeks to months (usually about 2 weeks)
acute transplant rejection - cause
direct allorecognition: graft dendritic cells travel to host lymph nodes and activate HOST T cells against donor HLA
acute transplant rejection - mechanism
T cells attack the vasculature of the graft, leading to vaculitis
acute transplant rejection - treatment/prevention
immunosuppression and histocompatibility matching
chronic transplant rejection - timing
months to years
chronic transplant rejection - cause
indirect allorecognition: recipient APCs present donor intracellular peptides to activate host T cells and B cells
chronic transplant rejection - mechanism
T cells secrete cytokines, leading to fibrosis and arteriosclerosis of graft
hyperacute transplant rejection - HSR type
type II HSR (antibody-mediated)
acute transplant rejection - HSR type
type IV HSR (T-cell mediated)
chronic transplant rejection - HSR type
type II/IV HSR (antibodies and Th1 cells)